Report
Chris Kallos, CFA
EUR 103.64 For Business Accounts Only

Increasing Competition Adds to Industry Weakness in Demand; Placing Monash IVF Group Under Review

Following the trading update from close peer Virtus Health, along with the release of Medicare volume data, we are revisiting our assumptions for Monash’s IVF business and pricing assumptions, given intensifying competition in Victoria and New South Wales. As such, we are placing our fair value estimate for no-moat-rated Monash IVF under review.
From an industry perspective, just-released fresh cycle volume data, reflecting both full-service and low-cost offerings from all participants, was disa...
Underlying
Monash IVF Group

Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Chris Kallos, CFA

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch